These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15000468

  • 1. Swellable matrices for the controlled-release of diclofenac sodium: formulation and in vitro studies.
    Bravo SA, Lamas MC, Salomon CJ.
    Pharm Dev Technol; 2004; 9(1):75-83. PubMed ID: 15000468
    [Abstract] [Full Text] [Related]

  • 2. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A, Ozkan Y, Işimer A.
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [Abstract] [Full Text] [Related]

  • 3. The effect of polymer blends on release profiles of diclofenac sodium from matrices.
    Samani SM, Montaseri H, Kazemi A.
    Eur J Pharm Biopharm; 2003 May; 55(3):351-5. PubMed ID: 12754011
    [Abstract] [Full Text] [Related]

  • 4. Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium.
    Al-Taani BM, Tashtoush BM.
    AAPS PharmSciTech; 2003 May; 4(3):E43. PubMed ID: 14621975
    [Abstract] [Full Text] [Related]

  • 5. Formulation and evaluation of diclofenac sodium using hydrophilic matrices.
    Rao YM, Veni JK, Jayasagar G.
    Drug Dev Ind Pharm; 2001 Sep; 27(8):759-66. PubMed ID: 11699827
    [Abstract] [Full Text] [Related]

  • 6. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
    Van Nguyen H, Nguyen VH, Lee BJ.
    Int J Pharm; 2016 Dec 30; 515(1-2):233-244. PubMed ID: 27744034
    [Abstract] [Full Text] [Related]

  • 7. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.
    Avachat A, Kotwal V.
    AAPS PharmSciTech; 2007 Oct 19; 8(4):E88. PubMed ID: 18181548
    [Abstract] [Full Text] [Related]

  • 8. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
    Elzayat EM, Abdel-Rahman AA, Ahmed SM, Alanazi FK, Habib WA, Sakr A.
    Acta Pol Pharm; 2016 Oct 19; 73(2):439-52. PubMed ID: 27180437
    [Abstract] [Full Text] [Related]

  • 9. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH, Taha NF, Badr RM, Mursi NM.
    Drug Discov Ther; 2012 Oct 19; 6(5):269-77. PubMed ID: 23229148
    [Abstract] [Full Text] [Related]

  • 10. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
    Bravo SA, Lamas MC, Salamón CJ.
    J Pharm Pharm Sci; 2002 Oct 19; 5(3):213-9. PubMed ID: 12553888
    [Abstract] [Full Text] [Related]

  • 11. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS, Quadir MA, Haider SS.
    J Pharm Pharm Sci; 2003 Oct 19; 6(2):282-91. PubMed ID: 12935440
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of ethylcellulose as matrices for controlled release drug delivery.
    Quadir MA, Chanda E, Haider SS, Reza MD, Datta BK.
    Pak J Pharm Sci; 2005 Apr 19; 18(2):29-34. PubMed ID: 16431395
    [Abstract] [Full Text] [Related]

  • 13. Controlled porosity osmotic pump system for the delivery of diclofenac sodium: in-vitro and in-vivo evaluation.
    Emara LH, Taha NF, El-Ashmawy AA, Raslan HM, Mursi NM.
    Pharm Dev Technol; 2014 Sep 19; 19(6):681-91. PubMed ID: 24320694
    [Abstract] [Full Text] [Related]

  • 14. Formulation and characterization of modified release tablets containing isoniazid using swellable polymers.
    Akhtar MF, Rabbani M, Sharif A, Akhtar B, Saleem A, Murtaza G.
    Afr J Tradit Complement Altern Med; 2011 Sep 19; 8(3):250-9. PubMed ID: 22468003
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of Prosopis africana Seed Gum as an Extended Release Polymer for Tablet Formulation.
    Nadaf S, Nnamani P, Jadhav N.
    AAPS PharmSciTech; 2015 Jun 19; 16(3):716-29. PubMed ID: 25523143
    [Abstract] [Full Text] [Related]

  • 16. Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet.
    Kadivar A, Kamalidehghan B, Javar HA, Davoudi ET, Zaharuddin ND, Sabeti B, Chung LY, Noordin MI.
    PLoS One; 2015 Jun 19; 10(6):e0126874. PubMed ID: 26035710
    [Abstract] [Full Text] [Related]

  • 17. Formulation and evaluation of diclofenac controlled release matrix tablets made of HPMC and Poloxamer 188 polymer: An assessment on mechanism of drug release.
    Al-Hanbali OA, Hamed R, Arafat M, Bakkour Y, Al-Matubsi H, Mansour R, Al-Bataineh Y, Aldhoun M, Sarfraz M, Dardas AKY.
    Pak J Pharm Sci; 2018 Jan 19; 31(1(Suppl.)):345-351. PubMed ID: 29386164
    [Abstract] [Full Text] [Related]

  • 18. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
    Kang WH, Nguyen HV, Park C, Choi YW, Lee BJ.
    Eur J Pharm Sci; 2017 May 01; 102():85-93. PubMed ID: 28263912
    [Abstract] [Full Text] [Related]

  • 19. Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.
    Abdullah MD, Bepary S, Rouf AS.
    Pak J Pharm Sci; 2008 Jan 01; 21(1):70-7. PubMed ID: 18166523
    [Abstract] [Full Text] [Related]

  • 20. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M, Naseef H, Vlachou M.
    Drug Dev Ind Pharm; 2010 Aug 01; 36(8):903-16. PubMed ID: 20196641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.